UNSPSC 51281654: Kanamycin a sulfate

This classification denotes an aminoglycoside antibiotic with the molecular formula C18H36N4O11.H2O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier J80EX28SMQ, chemically known as d-streptamine, o-3-amino-3-deoxy-.alpha.-d-glucopyranosyl(1->6)-o-(6-amino-6-deoxy-.alpha.-d-glucopyranosyl(1->4))-2-deoxy-, sulfate (1:1) (salt), but more generally known as kanamycin a sulfate, which bears US NIH Compound Identifier 32943.

UNSPSC 51281654 Kanamycin a sulfate is a Commodity code that represents a specific pharmaceutical active ingredient used in antibiotic formulations. State and local health agencies procure kanamycin sulfate as a component in drug manufacturing, pharmacy stockpiling, and emergency response inventories. The code appears in health department pharmaceutical procurement cycles, typically as part of broader pharmaceutical warehouse or emergency medication supply contracts. Issuing bodies include state health departments and county health authorities managing public health pharmacy operations and disease-control programs.

Recent state and local activity under this code remains limited. The Illinois Department of Public Health awarded a $2,999,999.11 piggyback pharmaceutical warehouse contract to Chartwell Rx LLC on August 28, 2026 through the MMCAP Infuse consortium (Solicitation 26482DPHPREPDB53392), though that award covered Doxycycline Hyclate and Ciprofloxacin Hydrochloride rather than kanamycin sulfate directly. Seminole County, Florida posted an IFB (IFB60459723LAS) on June 30, 2026 seeking Naloxone and drug deactivation systems, which similarly falls outside the kanamycin scope. The code shows no open solicitations specifically naming kanamycin sulfate as a line item in recent postings, suggesting either sporadic demand or procurement bundled within broader pharmaceutical framework agreements rather than standalone commodity buys.